Clinical and imaging correlations of bone turnover markers in prostate cancer patients with bone only metastases

Abstract

Bone markers are remarkably elevated in the serum of prostate cancer patients with metastatic bone disease and correlate with EOD. Paired correlations also suggest an accelerated but proportional (coupled) bone metabolism.